BRIEF-Quince Therapeutics - On Feb 9, Engaged Lifesci Capital For Strategic Alternatives - SEC Filing
Reuters
Feb 12
BRIEF-Quince Therapeutics - On Feb 9, Engaged Lifesci Capital For Strategic Alternatives - SEC Filing
Feb 12 (Reuters) - Quince Therapeutics Inc QNCX.O:
QUINCE THERAPEUTICS - ON FEB 9, ENGAGED LIFESCI CAPITAL FOR STRATEGIC ALTERNATIVES - SEC FILING
QUINCE THERAPEUTICS - PLANS TO FOCUS ON REVERSE MERGER - SEC FILING
QUINCE THERAPEUTICS - LEAD DRUG CANDIDATE EDSP FAILS IN NEAT TRIAL - SEC FILING
QUINCE THERAPEUTICS: DO NOT HAVE RESOURCES TO PURSUE FURTHER OPERATIONS ON LEAD DRUG CANDIDATE, EDSP
Source text: []
Further company coverage: QNCX.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.